Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 2Phase 4 1

Status

Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 3Plasma cell 2Other hematologic neoplasm 2

Conditions

Multiple Myeloma 323Lymphoma 86Leukemia 63Precursor Cell Lymphoblastic Leukemia-Lymphoma 62Lymphoma, Non-Hodgkin 62Hodgkin Disease 60Leukemia, Lymphocytic, Chronic, B-Cell 58Neoplasms, Plasma Cell 56Leukemia, Myeloid, Acute 50Lymphoma, Mantle-Cell 47Myelodysplastic Syndromes 44Lymphoma, Follicular 44Myeloproliferative Disorders 42Lymphoma, Large B-Cell, Diffuse 42Lymphoma, B-Cell, Marginal Zone 40Burkitt Lymphoma 40Neoplasms 39Lymphoma, Large-Cell, Immunoblastic 38Primary Myelofibrosis 37Lymphoma, T-Cell, Cutaneous 35Sezary Syndrome 33Mycosis Fungoides 33Leukemia, Myeloid, Chronic-Phase 33Leukemia, Myeloid, Accelerated Phase 33Congenital Abnormalities 31Hematologic Neoplasms 30Blast Crisis 30Leukemia, Hairy Cell 29Breast Neoplasms 29Leukemia, Myelomonocytic, Chronic 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Cytokine Release Syndrome × Plasma cell × Clear all
NCT07499128 2026-06-01

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

National Institutes of Health Clinical Center (CC)

Phase NA Enrolling by invitation
136 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Cytokine Release Syndrome, Lymphoma, Multiple Myeloma, Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07390071 2026-02-05

Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy

University of Utah

Phase NA Recruiting
40 enrolled
LymphoidPlasma cell

Cytokine Release Syndrome, Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡